Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

News Releases & Announcements

Filter Results

1386 News Releases Found

PD-L1 inhibitor at work blocking PD-L1 (red) from interacting with PD-1 (blue) on a T-cell. Credit: Getty Images
News Releases
6/5/2023

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

  • Kidney Cancer
Colorectal cancer cell illustration##SEMICOLON## Credit: Getty Images
News Releases
6/4/2023

New research from Dana-Farber Brigham Cancer Center and Memorial Sloan Kettering Cancer Center finds that radiation can be safely omitted in select patients with locally advanced rectal can

  • Rectal Cancer
Credit: Patrick Wen, MD
News Releases
6/4/2023

Clinical trial points to treatment advances for glioma patients for first time in decades

  • Brain Tumors
Oreofe O. Odejide, MD, MPH
News Releases
6/1/2023

Study suggests lymphoma patients with depression or anxiety experience shorter survival times

  • Lymphomas
Constantine Mitsiades, MD, PhD
News Releases
5/26/2023

CRISPR studies identify many promising therapeutic targets for multiple myeloma

  • Multiple Myeloma
_
News Releases
5/26/2023

Breast, rectal, kidney and brain cancer phase 3 trials headline Dana-Farber research at ASCO Annual Meeting

  • Research
_
News Releases
5/25/2023

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

  • Research
  • Breast Cancer
_
News Releases
5/24/2023

2nd Transatlantic Exchange Program focusses on Artificial Intelligence and Data Science in Oncology

  • Discovery
_
News Releases
5/22/2023

The Jimmy Fund Celebrates 75 years of Progress and Impact on May 22

News Releases
5/16/2023

Dana-Farber researchers report on the safety and activity of immune checkpoint inhibitors in people living with HIV and cancer